# Trialix - CLI & API Design Document

## User Experience Design for Clinical Trial Enrichment Analysis

---

## 1. Command Structure

```
trialix
â”‚
â”œâ”€â”€ analyze              # Main enrichment analysis workflow
â”‚   â”œâ”€â”€ --input         # Path to CSV data file (required)
â”‚   â”œâ”€â”€ --outcome       # Outcome column name (required)
â”‚   â”œâ”€â”€ --output        # Output directory (default: ./trialix_results/)
â”‚   â”œâ”€â”€ --top-n         # Number of top biomarkers (default: 5)
â”‚   â”œâ”€â”€ --min-auc       # Minimum AUC threshold (default: 0.6)
â”‚   â””â”€â”€ --format        # Output format: text|json|csv (default: text)
â”‚
â”œâ”€â”€ validate             # Validate input data format
â”‚   â”œâ”€â”€ --input         # Path to CSV file
â”‚   â””â”€â”€ --strict        # Enable strict validation
â”‚
â”œâ”€â”€ visualize            # Generate standalone plots from results
â”‚   â”œâ”€â”€ --results       # Path to results JSON
â”‚   â””â”€â”€ --output        # Output directory for plots
â”‚
â”œâ”€â”€ version              # Show version info
â”‚
â””â”€â”€ help                 # Show help documentation
```

---

## 2. CLI User Experience Flow

### 2.1 Basic Analysis Command

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ $ trialix analyze --input oncology_trial.csv --outcome responder       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 2.2 Terminal Output (Full Experience)

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                        TRIALIX v0.1.0                                     â•‘
â•‘              Clinical Trial Enrichment Analysis                           â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

ğŸ” Loading data from: oncology_trial.csv
   â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” 100% | 0.3s

âœ“ Data loaded successfully
  â”œâ”€ Total patients: 150
  â”œâ”€ Responders: 57 (38.0%)
  â”œâ”€ Non-responders: 93 (62.0%)
  â””â”€ Biomarkers found: 4 (pdl1_score, age, tmb, kras_mutation)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“Š Analyzing biomarkers...
   â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” 100% | 1.2s

   Biomarker Rankings:
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”
   â”‚ Biomarker          â”‚ Odds    â”‚ 95% CI           â”‚ p-value  â”‚ AUC   â”‚ Rank â”‚
   â”‚                    â”‚ Ratio   â”‚                  â”‚          â”‚       â”‚      â”‚
   â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”¤
   â”‚ pdl1_score         â”‚  3.20   â”‚ [1.80 - 5.70]    â”‚ <0.001   â”‚ 0.78  â”‚ â­â­â­ â”‚
   â”‚ age                â”‚  1.05   â”‚ [1.01 - 1.09]    â”‚  0.012   â”‚ 0.64  â”‚ â­â­  â”‚
   â”‚ tmb                â”‚  1.80   â”‚ [1.02 - 3.18]    â”‚  0.045   â”‚ 0.61  â”‚ â­    â”‚
   â”‚ kras_mutation      â”‚  1.30   â”‚ [0.68 - 2.48]    â”‚  0.210   â”‚ 0.55  â”‚  -   â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”˜

   âœ“ Found 3 significant biomarkers (p < 0.05)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ¯ Optimizing cutoff values...
   â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” 100% | 0.8s

   Optimal Cutoffs (Youden's Index):
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ Biomarker          â”‚ Cutoff    â”‚ Sensitivity  â”‚ Specificity  â”‚ Youden J â”‚
   â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
   â”‚ pdl1_score         â”‚  â‰¥ 50%    â”‚    0.75      â”‚    0.68      â”‚   0.43   â”‚
   â”‚ age                â”‚  â‰¥ 55 yr  â”‚    0.62      â”‚    0.58      â”‚   0.20   â”‚
   â”‚ tmb                â”‚  â‰¥ 10.0   â”‚    0.58      â”‚    0.55      â”‚   0.13   â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“ˆ Calculating enrichment impact...
   â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” 100% | 0.5s

   â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
   â•‘               RECOMMENDED INCLUSION CRITERIA                           â•‘
   â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

   Suggested Enrollment Criteria:
   âœ“ PD-L1 tumor proportion score â‰¥ 50%
   âœ“ Age â‰¥ 55 years

   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚                         ENRICHMENT IMPACT                               â”‚
   â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
   â”‚                                                                         â”‚
   â”‚  Unenriched Population:                                                 â”‚
   â”‚  â”œâ”€ Response Rate: 38.0%                                                â”‚
   â”‚  â””â”€ Eligible Patients: 100% (all screened)                              â”‚
   â”‚                                                                         â”‚
   â”‚  Enriched Population (PDL1â‰¥50% + Ageâ‰¥55):                               â”‚
   â”‚  â”œâ”€ Response Rate: 58.0%  â†‘ +20.0 pp                                    â”‚
   â”‚  â”œâ”€ Eligible Patients: 35.0% of screened                                â”‚
   â”‚  â”œâ”€ Relative Improvement: 1.53x response rate                           â”‚
   â”‚  â””â”€ Number Needed to Screen: 2.9 patients per randomized                â”‚
   â”‚                                                                         â”‚
   â”‚  Trial Power Implications:                                              â”‚
   â”‚  â””â”€ Same statistical power with 43% fewer patients (enriched cohort)    â”‚
   â”‚                                                                         â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“Š Generating visualizations...
   â”œâ”€ Biomarker distributions by response... âœ“
   â”œâ”€ ROC curves for top biomarkers... âœ“
   â””â”€ Enrichment impact chart... âœ“

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ’¾ Exporting results to: ./trialix_results/

   Files created:
   â”œâ”€ ğŸ“„ biomarker_rankings.csv
   â”œâ”€ ğŸ“„ optimal_cutoffs.csv
   â”œâ”€ ğŸ“„ enrichment_summary.json
   â”œâ”€ ğŸ“„ recommended_criteria.txt
   â”œâ”€ ğŸ“Š plots/biomarker_distributions.png
   â”œâ”€ ğŸ“Š plots/roc_curves.png
   â””â”€ ğŸ“Š plots/enrichment_impact.png

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

âœ… Analysis complete! (Total time: 2.8s)

   Next Steps:
   1. Review biomarker rankings in biomarker_rankings.csv
   2. Examine plots in ./trialix_results/plots/
   3. Share recommended_criteria.txt with clinical team
   4. Refine criteria using: trialix analyze --min-auc 0.65 --top-n 3

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
```

---

## 3. Visualization Examples (ASCII Previews)

### 3.1 Biomarker Distribution Plot (Conceptual)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚              Biomarker Distributions by Response Status               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                       â”‚
â”‚  PD-L1 Score (%)                                                      â”‚
â”‚  100â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚   90â”‚                                              â•”â•â•â•â•—            â”‚ â”‚
â”‚   80â”‚                                              â•‘   â•‘            â”‚ â”‚
â”‚   70â”‚                                         â•”â•â•â•â•â•¬â•â•â•â•¬â•â•â•â•â•—       â”‚ â”‚
â”‚   60â”‚                                         â•‘    â•‘   â•‘    â•‘       â”‚ â”‚
â”‚   50â”‚                          â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•¬â•â•â•â•â•©â•â•â•â•©â•â•â•â•â•£       â”‚ â”‚
â”‚   40â”‚                          â•‘              â•‘              â•‘       â”‚ â”‚
â”‚   30â”‚     â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•¬â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£              â•‘       â”‚ â”‚
â”‚   20â”‚     â•‘                    â•‘              â•‘              â•‘       â”‚ â”‚
â”‚   10â”‚â”€â”€â”€â”€â”€â•¨â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•¨â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•¨â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•¨â”€â”€â”€â”€â”€â”€â”€â”‚ â”‚
â”‚    0â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚ â”‚
â”‚           Non-Responders                Responders                   â”‚ â”‚
â”‚                                                                       â”‚
â”‚  p < 0.001 (Mann-Whitney U test)                                     â”‚
â”‚  Median: Non-Resp = 28%, Responders = 62%                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.2 ROC Curve (Conceptual)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                 ROC Curves - Top Predictive Biomarkers                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                       â”‚
â”‚ True                                                                  â”‚
â”‚ Positive                                                              â”‚
â”‚ Rate     1.0â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â”‚
â”‚             â”‚                                          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚
â”‚         0.8 â”‚                                  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ            â”‚   â”‚
â”‚             â”‚                          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                    â”‚   â”‚
â”‚         0.6 â”‚                  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â† PD-L1 (AUC=0.78)      â”‚   â”‚
â”‚             â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                    â”‚   â”‚
â”‚         0.4 â”‚      â–ˆâ–ˆâ–ˆâ–ˆ â† Age (AUC=0.64)                           â”‚   â”‚
â”‚             â”‚  â–ˆâ–ˆâ–ˆâ–ˆ                                                â”‚   â”‚
â”‚         0.2 â”‚â–ˆâ–ˆ â† TMB (AUC=0.61)                                   â”‚   â”‚
â”‚             â”‚                                                      â”‚   â”‚
â”‚         0.0 â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚             0.0    0.2    0.4    0.6    0.8    1.0                    â”‚
â”‚                     False Positive Rate                               â”‚
â”‚                                                                       â”‚
â”‚  â”€â”€â”€ PD-L1 Score (AUC=0.78)    â”€ â”€ Age (AUC=0.64)                    â”‚
â”‚  Â·Â·Â· TMB (AUC=0.61)             â”€â”€â”€ Random (AUC=0.50)                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.3 Enrichment Impact Chart (Conceptual)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                 Response Rate: Unenriched vs Enriched                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                       â”‚
â”‚  Response                                                             â”‚
â”‚  Rate (%)                                                             â”‚
â”‚         60â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â”‚
â”‚           â”‚                                    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚   â”‚
â”‚         50â”‚                                    â–ˆ  Enriched  â–ˆ   â”‚   â”‚
â”‚           â”‚                                    â–ˆ   58.0%    â–ˆ   â”‚   â”‚
â”‚         40â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚   â”‚
â”‚           â”‚          â–ˆ  Unenriched â–ˆ           â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚   â”‚
â”‚         30â”‚          â–ˆ   38.0%     â–ˆ           â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚   â”‚
â”‚           â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚   â”‚
â”‚         20â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚   â”‚
â”‚           â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                            â”‚   â”‚
â”‚         10â”‚          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                            â”‚   â”‚
â”‚           â”‚                                                      â”‚   â”‚
â”‚          0â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚               All Patients         PDL1â‰¥50% + Ageâ‰¥55                 â”‚
â”‚                (n=150)                 (n=52)                         â”‚
â”‚                                                                       â”‚
â”‚  Population Size:  100% â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€> 35%                â”‚
â”‚  Response Rate:    38%  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€> 58%  (+20pp)       â”‚
â”‚  Enrichment Factor: â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€> 1.53x              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 4. Python API Design

### 4.1 Basic Workflow

```python
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         PYTHON API WORKFLOW                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

from trialix import TrialEnrichment

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 1: Initialize analyzer
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

analyzer = TrialEnrichment(
    data="oncology_trial.csv",
    outcome="responder"
)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 2: Load and validate data
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

analyzer.load_data()
# Returns: DataSummary object
#   - n_patients: 150
#   - n_responders: 57
#   - n_nonresponders: 93
#   - biomarkers: ['pdl1_score', 'age', 'tmb', 'kras_mutation']

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 3: Discover predictive biomarkers
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

biomarkers = analyzer.find_biomarkers(top_n=5, min_auc=0.6)
# Returns: pandas DataFrame
#
#    biomarker      OR    CI_lower  CI_upper  p_value   AUC
# 0  pdl1_score    3.20      1.80      5.70    0.000   0.78
# 1  age           1.05      1.01      1.09    0.012   0.64
# 2  tmb           1.80      1.02      3.18    0.045   0.61

print(biomarkers)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 4: Optimize cutoff values
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

cutoffs = analyzer.optimize_cutoffs()
# Returns: dict
#   {
#     'pdl1_score': {'cutoff': 50.0, 'sensitivity': 0.75, 'specificity': 0.68},
#     'age': {'cutoff': 55.0, 'sensitivity': 0.62, 'specificity': 0.58},
#     'tmb': {'cutoff': 10.0, 'sensitivity': 0.58, 'specificity': 0.55}
#   }

print(cutoffs)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 5: Generate enrollment criteria recommendations
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

criteria = analyzer.suggest_criteria()
# Returns: EnrichmentCriteria object

print(criteria.summary())
# Output:
#   Recommended Inclusion Criteria:
#     â€¢ PD-L1 tumor proportion score â‰¥ 50%
#     â€¢ Age â‰¥ 55 years
#
#   Impact:
#     â€¢ Response rate: 58.0% (vs 38.0% unenriched)
#     â€¢ Eligible population: 35.0%
#     â€¢ Enrichment factor: 1.53x

# Access individual attributes
print(f"Response rate: {criteria.response_rate_enriched:.1%}")
print(f"Eligible fraction: {criteria.eligible_fraction:.1%}")

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 6: Generate visualizations
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Generate all plots
analyzer.plot_all(save_to="results/plots/")

# Or generate individual plots
analyzer.plot_biomarkers(biomarkers=['pdl1_score', 'age'], save_to="plots/")
analyzer.plot_roc_curves(save_to="plots/")
analyzer.plot_enrichment_impact(save_to="plots/")

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Step 7: Export results
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

analyzer.export(output_dir="results/", format="csv")
# Creates:
#   - results/biomarker_rankings.csv
#   - results/optimal_cutoffs.csv
#   - results/enrichment_summary.json

# Or export to JSON for programmatic access
results_json = analyzer.to_json()
# Returns: JSON string with all analysis results
```

### 4.2 Advanced API Usage

```python
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      ADVANCED WORKFLOW EXAMPLES                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Custom Biomarker Selection
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Analyze specific biomarkers only
analyzer = TrialEnrichment(data="trial.csv", outcome="responder")
analyzer.load_data()

biomarkers = analyzer.find_biomarkers(
    biomarker_list=['pdl1_score', 'age'],  # Only analyze these
    min_auc=0.65,                          # Higher AUC threshold
    top_n=2                                 # Return top 2
)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Custom Cutoff Optimization
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Override automatic cutoff optimization
cutoffs = analyzer.optimize_cutoffs(
    method='youden',           # Options: 'youden', 'cost_sensitive'
    min_sensitivity=0.7,       # Require at least 70% sensitivity
    min_specificity=0.6        # Require at least 60% specificity
)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Sensitivity Analysis
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Test different cutoff scenarios
for pdl1_cutoff in [40, 50, 60, 70]:
    criteria = analyzer.suggest_criteria(
        custom_cutoffs={'pdl1_score': pdl1_cutoff}
    )
    print(f"PDL1 â‰¥{pdl1_cutoff}%: Response={criteria.response_rate_enriched:.1%}")

# Output:
#   PDL1 â‰¥40%: Response=52.0%
#   PDL1 â‰¥50%: Response=58.0%
#   PDL1 â‰¥60%: Response=64.0%
#   PDL1 â‰¥70%: Response=68.0%

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Integration with pandas/scikit-learn
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

import pandas as pd

# Access underlying data
df = analyzer.data  # Returns pandas DataFrame
responders = df[df['outcome'] == 'responder']

# Get predictions for new patients
new_patients = pd.read_csv("new_cohort.csv")
predictions = analyzer.predict_enrichment_eligibility(new_patients)
# Returns: Boolean array indicating eligibility based on criteria

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# Jupyter Notebook Integration
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Display plots inline
%matplotlib inline

analyzer.plot_biomarkers(display=True)  # Shows plot in notebook
analyzer.plot_roc_curves(display=True)

# Interactive exploration
biomarkers_df = analyzer.find_biomarkers()
biomarkers_df.style.background_gradient(subset=['AUC'], cmap='RdYlGn')
```

---

## 5. Package Architecture

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        TRIALIX PACKAGE ARCHITECTURE                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

                              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                              â”‚   User Input    â”‚
                              â”‚  (CSV file)     â”‚
                              â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                       â”‚
                       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                       â”‚                               â”‚
                  â”Œâ”€â”€â”€â”€â–¼â”€â”€â”€â”€â”                    â”Œâ”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”
                  â”‚   CLI   â”‚                    â”‚ Python    â”‚
                  â”‚  (Click)â”‚                    â”‚    API    â”‚
                  â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”˜                    â””â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”˜
                       â”‚                               â”‚
                       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                       â”‚
                        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                        â”‚    CORE ENGINE              â”‚
                        â”‚  (trialix.core)             â”‚
                        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                       â”‚
        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
        â”‚                              â”‚                              â”‚
   â”Œâ”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ Data Loader â”‚          â”‚ Biomarker Analyzer  â”‚      â”‚ Criteria Generator  â”‚
   â”‚             â”‚          â”‚                     â”‚      â”‚                     â”‚
   â”‚ â€¢ CSV read  â”‚          â”‚ â€¢ Logistic Reg      â”‚      â”‚ â€¢ Cutoff Optimizer  â”‚
   â”‚ â€¢ Validate  â”‚          â”‚ â€¢ OR calculation    â”‚      â”‚ â€¢ Impact Estimator  â”‚
   â”‚ â€¢ Clean     â”‚          â”‚ â€¢ ROC/AUC           â”‚      â”‚ â€¢ Recommendations   â”‚
   â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜      â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        â”‚                              â”‚                              â”‚
        â”‚                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                  â”‚
        â”‚                    â”‚  Statistical Engine â”‚                  â”‚
        â”‚                    â”‚   (scipy, sklearn)  â”‚                  â”‚
        â”‚                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                  â”‚
        â”‚                                                              â”‚
        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                     â”‚
                     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                     â”‚                               â”‚
              â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”€â”€â”
              â”‚ Visualizer  â”‚              â”‚   Exporter       â”‚
              â”‚             â”‚              â”‚                  â”‚
              â”‚ â€¢ Plots     â”‚              â”‚ â€¢ CSV            â”‚
              â”‚ â€¢ Charts    â”‚              â”‚ â€¢ JSON           â”‚
              â”‚ â€¢ Figures   â”‚              â”‚ â€¢ Text reports   â”‚
              â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”˜              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                     â”‚                               â”‚
                     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                     â”‚
                              â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”
                              â”‚   Output    â”‚
                              â”‚   Files     â”‚
                              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜


â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         MODULE BREAKDOWN                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                           â”‚
â”‚  trialix/                                                                 â”‚
â”‚  â”œâ”€â”€ __init__.py                    # Package initialization             â”‚
â”‚  â”‚   â””â”€â”€ Exports: TrialEnrichment                                        â”‚
â”‚  â”‚                                                                        â”‚
â”‚  â”œâ”€â”€ core/                          # Core analysis modules              â”‚
â”‚  â”‚   â”œâ”€â”€ __init__.py                                                     â”‚
â”‚  â”‚   â”œâ”€â”€ data_loader.py             # CSV ingestion, validation          â”‚
â”‚  â”‚   â”‚   â””â”€â”€ Classes: DataLoader, DataValidator                          â”‚
â”‚  â”‚   â”œâ”€â”€ biomarker_analysis.py     # Logistic regression, OR calc        â”‚
â”‚  â”‚   â”‚   â””â”€â”€ Classes: BiomarkerAnalyzer                                  â”‚
â”‚  â”‚   â”œâ”€â”€ cutoff_optimizer.py       # ROC analysis, Youden's Index        â”‚
â”‚  â”‚   â”‚   â””â”€â”€ Classes: CutoffOptimizer                                    â”‚
â”‚  â”‚   â””â”€â”€ criteria_generator.py     # Enrollment criteria logic           â”‚
â”‚  â”‚       â””â”€â”€ Classes: CriteriaGenerator, EnrichmentCriteria              â”‚
â”‚  â”‚                                                                        â”‚
â”‚  â”œâ”€â”€ visualizations/                # Plotting modules                   â”‚
â”‚  â”‚   â”œâ”€â”€ __init__.py                                                     â”‚
â”‚  â”‚   â”œâ”€â”€ biomarker_plots.py        # Distribution plots                  â”‚
â”‚  â”‚   â”œâ”€â”€ roc_plots.py              # ROC curves                          â”‚
â”‚  â”‚   â””â”€â”€ enrichment_plots.py       # Impact charts                       â”‚
â”‚  â”‚                                                                        â”‚
â”‚  â”œâ”€â”€ cli/                           # Command-line interface             â”‚
â”‚  â”‚   â”œâ”€â”€ __init__.py                                                     â”‚
â”‚  â”‚   â””â”€â”€ commands.py               # Click commands                      â”‚
â”‚  â”‚                                                                        â”‚
â”‚  â”œâ”€â”€ api/                           # Python API                         â”‚
â”‚  â”‚   â”œâ”€â”€ __init__.py                                                     â”‚
â”‚  â”‚   â””â”€â”€ enrichment.py             # TrialEnrichment class               â”‚
â”‚  â”‚                                                                        â”‚
â”‚  â””â”€â”€ utils/                         # Utilities                          â”‚
â”‚      â”œâ”€â”€ __init__.py                                                     â”‚
â”‚      â”œâ”€â”€ validators.py             # Input validation                    â”‚
â”‚      â”œâ”€â”€ formatters.py             # Output formatting                   â”‚
â”‚      â””â”€â”€ constants.py              # Constants (column names, defaults)  â”‚
â”‚                                                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 6. Data Flow Diagram

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        END-TO-END DATA FLOW                               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜


  INPUT DATA                 PROCESSING                      OUTPUT
  â•â•â•â•â•â•â•â•â•â•                 â•â•â•â•â•â•â•â•â•â•                      â•â•â•â•â•â•

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚             â”‚         â”‚                  â”‚         â”‚                  â”‚
â”‚ trial.csv   â”‚â”€â”€â”€â”€â”€â”€â”€â”€â–¶â”‚  Data Loader     â”‚â”€â”€â”€â”€â”€â”€â”€â”€â–¶â”‚  Validated       â”‚
â”‚             â”‚         â”‚  â€¢ Read CSV      â”‚         â”‚  DataFrame       â”‚
â”‚ patient_id  â”‚         â”‚  â€¢ Check cols    â”‚         â”‚  (150 patients)  â”‚
â”‚ outcome     â”‚         â”‚  â€¢ Validate      â”‚         â”‚                  â”‚
â”‚ biomarker_1 â”‚         â”‚  â€¢ Clean NA      â”‚         â”‚                  â”‚
â”‚ biomarker_2 â”‚         â”‚                  â”‚         â”‚                  â”‚
â”‚ ...         â”‚         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                                               â”‚
                                                              â”‚
                        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                        â”‚
                        â–¼
              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
              â”‚  Biomarker        â”‚
              â”‚  Analysis         â”‚
              â”‚  â€¢ Logistic Reg   â”‚
              â”‚  â€¢ Calculate OR   â”‚â”€â”€â”€â”€â”€â”€â”€â”
              â”‚  â€¢ ROC/AUC        â”‚       â”‚
              â”‚  â€¢ P-values       â”‚       â”‚
              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
                        â”‚                 â”‚
                        â–¼                 â–¼
              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
              â”‚  Cutoff           â”‚  â”‚  Biomarker       â”‚
              â”‚  Optimization     â”‚  â”‚  Rankings        â”‚
              â”‚  â€¢ Youden Index   â”‚  â”‚  (DataFrame)     â”‚
              â”‚  â€¢ Sensitivity    â”‚  â”‚                  â”‚
              â”‚  â€¢ Specificity    â”‚  â”‚  pdl1: OR=3.2    â”‚
              â””â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  age:  OR=1.05   â”‚
                      â”‚              â”‚  ...             â”‚
                      â–¼              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
              â”‚  Criteria         â”‚
              â”‚  Generation       â”‚
              â”‚  â€¢ Apply cutoffs  â”‚
              â”‚  â€¢ Calculate RR   â”‚
              â”‚  â€¢ Estimate NNS   â”‚
              â””â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                      â”‚
          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
          â”‚           â”‚           â”‚
          â–¼           â–¼           â–¼
    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
    â”‚ Plots   â”‚ â”‚ CSV     â”‚ â”‚ JSON        â”‚
    â”‚         â”‚ â”‚ Tables  â”‚ â”‚ Results     â”‚
    â”‚ â€¢ ROC   â”‚ â”‚         â”‚ â”‚             â”‚
    â”‚ â€¢ Dist  â”‚ â”‚ rankingsâ”‚ â”‚ {"criteria":â”‚
    â”‚ â€¢ Impactâ”‚ â”‚ cutoffs â”‚ â”‚  "pdl1>=50"}â”‚
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

                   OUTPUT FILES:
         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
         â”‚ trialix_results/                     â”‚
         â”‚ â”œâ”€â”€ biomarker_rankings.csv           â”‚
         â”‚ â”œâ”€â”€ optimal_cutoffs.csv              â”‚
         â”‚ â”œâ”€â”€ enrichment_summary.json          â”‚
         â”‚ â”œâ”€â”€ recommended_criteria.txt         â”‚
         â”‚ â””â”€â”€ plots/                           â”‚
         â”‚     â”œâ”€â”€ biomarker_distributions.png  â”‚
         â”‚     â”œâ”€â”€ roc_curves.png               â”‚
         â”‚     â””â”€â”€ enrichment_impact.png        â”‚
         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 7. Error Handling & User Feedback

### 7.1 Input Validation Errors

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ $ trialix analyze --input trial.csv --outcome response                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

âŒ Error: Missing required column 'response'

   Available columns in trial.csv:
   â”œâ”€ patient_id
   â”œâ”€ outcome          â† Did you mean this?
   â”œâ”€ age
   â””â”€ pdl1_score

   Suggestion: Use --outcome outcome instead of --outcome response

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
```

### 7.2 Insufficient Data Warning

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ $ trialix analyze --input small_trial.csv --outcome responder          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

âš ï¸  Warning: Small sample size detected

   Total patients: 35
   Responders: 8 (22.9%)
   Non-responders: 27 (77.1%)

   Recommendations:
   â€¢ Minimum recommended sample size: 50 patients
   â€¢ Consider combining with additional trial data
   â€¢ Results may have limited statistical power

   Continue anyway? [y/N]: _
```

### 7.3 No Significant Biomarkers

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                        TRIALIX v0.1.0                                     â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

ğŸ” Loading data... âœ“
ğŸ“Š Analyzing biomarkers... âœ“

âš ï¸  No significant biomarkers found (p < 0.05)

   Biomarker Rankings:
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ Biomarker          â”‚ Odds    â”‚ 95% CI           â”‚ p-value  â”‚ AUC   â”‚
   â”‚                    â”‚ Ratio   â”‚                  â”‚          â”‚       â”‚
   â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¤
   â”‚ biomarker_A        â”‚  1.45   â”‚ [0.82 - 2.57]    â”‚  0.180   â”‚ 0.58  â”‚
   â”‚ biomarker_B        â”‚  1.22   â”‚ [0.71 - 2.10]    â”‚  0.450   â”‚ 0.53  â”‚
   â”‚ biomarker_C        â”‚  0.89   â”‚ [0.48 - 1.65]    â”‚  0.710   â”‚ 0.49  â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”˜

   Recommendations:
   â€¢ Consider alternative biomarkers or endpoints
   â€¢ Check data quality and outcome definitions
   â€¢ May need larger sample size for detection power

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
```

---

## 8. File Output Structure

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        OUTPUT DIRECTORY STRUCTURE                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

trialix_results/
â”‚
â”œâ”€â”€ biomarker_rankings.csv
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   â”‚ biomarker,odds_ratio,ci_lower,ci_upper,p_value,auc             â”‚
â”‚   â”‚ pdl1_score,3.20,1.80,5.70,0.000,0.78                           â”‚
â”‚   â”‚ age,1.05,1.01,1.09,0.012,0.64                                  â”‚
â”‚   â”‚ tmb,1.80,1.02,3.18,0.045,0.61                                  â”‚
â”‚   â”‚ kras_mutation,1.30,0.68,2.48,0.210,0.55                        â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚
â”œâ”€â”€ optimal_cutoffs.csv
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   â”‚ biomarker,cutoff,sensitivity,specificity,youden_index          â”‚
â”‚   â”‚ pdl1_score,50.0,0.75,0.68,0.43                                 â”‚
â”‚   â”‚ age,55.0,0.62,0.58,0.20                                        â”‚
â”‚   â”‚ tmb,10.0,0.58,0.55,0.13                                        â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚
â”œâ”€â”€ enrichment_summary.json
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   â”‚ {                                                               â”‚
â”‚   â”‚   "criteria": [                                                 â”‚
â”‚   â”‚     "pdl1_score >= 50.0",                                       â”‚
â”‚   â”‚     "age >= 55.0"                                               â”‚
â”‚   â”‚   ],                                                            â”‚
â”‚   â”‚   "response_rate_unenriched": 0.38,                             â”‚
â”‚   â”‚   "response_rate_enriched": 0.58,                               â”‚
â”‚   â”‚   "eligible_fraction": 0.35,                                    â”‚
â”‚   â”‚   "enrichment_factor": 1.53,                                    â”‚
â”‚   â”‚   "number_needed_to_screen": 2.9                                â”‚
â”‚   â”‚ }                                                               â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚
â”œâ”€â”€ recommended_criteria.txt
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   â”‚ RECOMMENDED INCLUSION CRITERIA                                  â”‚
â”‚   â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                         â”‚
â”‚   â”‚                                                                 â”‚
â”‚   â”‚ Based on analysis of 150 patients, the following criteria      â”‚
â”‚   â”‚ are recommended to enrich for treatment responders:            â”‚
â”‚   â”‚                                                                 â”‚
â”‚   â”‚ 1. PD-L1 tumor proportion score â‰¥ 50%                           â”‚
â”‚   â”‚ 2. Age â‰¥ 55 years                                               â”‚
â”‚   â”‚                                                                 â”‚
â”‚   â”‚ IMPACT ESTIMATE                                                 â”‚
â”‚   â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                 â”‚
â”‚   â”‚ Response Rate:                                                  â”‚
â”‚   â”‚   â€¢ Unenriched: 38.0%                                           â”‚
â”‚   â”‚   â€¢ Enriched: 58.0% (+20.0 percentage points)                   â”‚
â”‚   â”‚                                                                 â”‚
â”‚   â”‚ Population Impact:                                              â”‚
â”‚   â”‚   â€¢ Eligible patients: 35.0% of screened population             â”‚
â”‚   â”‚   â€¢ Enrichment factor: 1.53x response rate improvement          â”‚
â”‚   â”‚   â€¢ Number needed to screen: 2.9 patients per randomized        â”‚
â”‚   â”‚                                                                 â”‚
â”‚   â”‚ Statistical Significance:                                       â”‚
â”‚   â”‚   â€¢ PD-L1 score: p < 0.001, AUC = 0.78                          â”‚
â”‚   â”‚   â€¢ Age: p = 0.012, AUC = 0.64                                  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚
â””â”€â”€ plots/
    â”œâ”€â”€ biomarker_distributions.png    (1200x800 px, 300 DPI)
    â”œâ”€â”€ roc_curves.png                 (1200x800 px, 300 DPI)
    â””â”€â”€ enrichment_impact.png          (1200x800 px, 300 DPI)
```

---

## 9. Interactive Features (Future Enhancements)

### 9.1 Interactive Cutoff Adjustment (Future)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                   INTERACTIVE CUTOFF EXPLORER (v0.2+)                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Adjust PD-L1 cutoff:  [â”â”â”â”â”â”â”â”â”â—â”â”â”â”â”â”â”â”â”â”]  50%
                       0%                  100%

Current criteria: PDL1 â‰¥ 50%

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Response Rate: 58.0%  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“        â”‚
â”‚ Eligible Pop:  35.0%  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“ â”‚
â”‚ Sensitivity:   0.75   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“         â”‚
â”‚ Specificity:   0.68   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Press 'Enter' to apply | 'R' to reset | 'Q' to quit
```

---

## 10. Design Principles

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                          DESIGN PRINCIPLES                                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                           â”‚
â”‚  1. CLARITY OVER COMPLEXITY                                               â”‚
â”‚     â€¢ Simple, intuitive commands (no hidden flags)                        â”‚
â”‚     â€¢ Self-documenting output (explain what each metric means)            â”‚
â”‚     â€¢ Sensible defaults (works without configuration)                     â”‚
â”‚                                                                           â”‚
â”‚  2. PROGRESSIVE DISCLOSURE                                                â”‚
â”‚     â€¢ Basic usage is simple (trialix analyze --input data.csv)            â”‚
â”‚     â€¢ Advanced features available for power users                         â”‚
â”‚     â€¢ Helpful hints in output ("Next Steps: ...")                         â”‚
â”‚                                                                           â”‚
â”‚  3. FAIL GRACEFULLY                                                       â”‚
â”‚     â€¢ Clear error messages with actionable suggestions                    â”‚
â”‚     â€¢ Validate early (catch errors before long computation)               â”‚
â”‚     â€¢ Warnings for edge cases (small sample size, no biomarkers)          â”‚
â”‚                                                                           â”‚
â”‚  4. FAST FEEDBACK                                                         â”‚
â”‚     â€¢ Progress bars for long operations                                   â”‚
â”‚     â€¢ Streaming output (show results as they're computed)                 â”‚
â”‚     â€¢ <2 minute total analysis time (MVP goal)                            â”‚
â”‚                                                                           â”‚
â”‚  5. INTEROPERABILITY                                                      â”‚
â”‚     â€¢ Output standard formats (CSV, JSON, PNG)                            â”‚
â”‚     â€¢ Integrate with existing workflows (pandas, scikit-learn)            â”‚
â”‚     â€¢ No lock-in (users own their data and results)                       â”‚
â”‚                                                                           â”‚
â”‚  6. PROFESSIONAL QUALITY                                                  â”‚
â”‚     â€¢ Publication-ready plots (high DPI, proper labels)                   â”‚
â”‚     â€¢ Statistical rigor (confidence intervals, p-values)                  â”‚
â”‚     â€¢ Reproducible results (fixed random seeds, versioned output)         â”‚
â”‚                                                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 11. Command Reference Card

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      TRIALIX COMMAND QUICK REFERENCE                      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                           â”‚
â”‚  BASIC USAGE                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                             â”‚
â”‚  $ trialix analyze --input DATA.csv --outcome COLUMN                      â”‚
â”‚                                                                           â”‚
â”‚  COMMON OPTIONS                                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                          â”‚
â”‚  --output DIR           Output directory (default: ./trialix_results/)    â”‚
â”‚  --top-n N              Number of top biomarkers (default: 5)             â”‚
â”‚  --min-auc FLOAT        Minimum AUC threshold (default: 0.6)              â”‚
â”‚  --format FORMAT        Output format: text|json|csv (default: text)      â”‚
â”‚                                                                           â”‚
â”‚  UTILITIES                                                                â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                               â”‚
â”‚  $ trialix validate --input DATA.csv                                      â”‚
â”‚  $ trialix visualize --results results.json --output plots/               â”‚
â”‚  $ trialix version                                                        â”‚
â”‚  $ trialix help                                                           â”‚
â”‚                                                                           â”‚
â”‚  EXAMPLES                                                                 â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                                â”‚
â”‚  # Basic analysis                                                         â”‚
â”‚  $ trialix analyze --input trial.csv --outcome responder                  â”‚
â”‚                                                                           â”‚
â”‚  # Custom thresholds                                                      â”‚
â”‚  $ trialix analyze --input trial.csv --outcome responder \                â”‚
â”‚      --min-auc 0.65 --top-n 3                                             â”‚
â”‚                                                                           â”‚
â”‚  # JSON output for pipelines                                              â”‚
â”‚  $ trialix analyze --input trial.csv --outcome responder \                â”‚
â”‚      --format json --output results/                                      â”‚
â”‚                                                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

**Document Version**: 1.0
**Last Updated**: 2025-12-03
**Status**: Design Specification - Ready for Implementation
